Helix BioPharma Corp
TSX:HBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Helix BioPharma Corp
TSX:HBP
|
CA |
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
|
Sunstone Metals Ltd
ASX:STM
|
AU |
|
N
|
Northrop Grumman Corp
SWB:NTH
|
US |
|
C
|
Carrefour SA
DUS:CAR
|
FR |
|
P
|
Panjawattana Plastic PCL
SET:PJW
|
TH |
|
S
|
Sumitomo Corp
DUS:SUMA
|
JP |
|
Uniti SA
PAR:ALUNT
|
FR |
|
MP Materials Corp
NYSE:MP
|
US |
|
Tatton Asset Management PLC
F:2T7
|
UK |
|
BP PLC
LSE:BP
|
UK |
|
Brightstar Resources Ltd
OTC:BTRAF
|
AU |
|
E
|
Eventbrite Inc
SWB:EB4
|
US |
|
V
|
Verisk Analytics Inc
XMUN:VA7A
|
US |
|
U
|
United Overseas Insurance Ltd
SGX:U13
|
SG |
|
Autoneum Holding AG
LSE:0QOB
|
CH |
|
Anritsu Corp
TSE:6754
|
JP |
Bankruptcy Probability
Helix BioPharma Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Helix BioPharma Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Helix BioPharma Corp
TSX:HBP
|
75.6m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
506.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
196.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Helix BioPharma Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Helix BioPharma Corp has total debt of 359k CAD. This includes both short-term (359k CAD) and long-term (0 CAD) debt.
You can find a full breakdown on its Balance Sheet.